ACET logo

Adicet Bio, Inc. Common Stock


ACET: Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. The company operates and manages its business as one reportable and operating segment, which is the business of research and development of allogeneic immunotherapies for cancer and other diseases.


Show ACET Financials

Consumer Interest
SEC Filings

Recent trades of ACET by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ACET's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods for selective expansion of γδ t-cell populations and compositions thereof Apr. 12, 2022
  • Patent Title: Engineered γδ t-cells Oct. 05, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ACET in WallStreetBets Daily Discussion


Recent insights relating to ACET

CNBC Recommendations

Recent picks made for ACET stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ACET

Corporate Flights

Flights by private jets registered to ACET